Synapse - Hani Hassoun

Search Within

Hani Hassoun

Results (339)

Induction with bortezomib and dexamethasone (BD) followed by risk adapted high dose melphalan and autologous stem cell transplantation and BD consolidation in patients with AL amyloidosis: A phase II feasibility study

Meeting Abstract

Landau, H.; Montanez, N.; Cowan, A.; Hoover, E.; Flombaum, C.; Liu, J.; Maurer, M.; Lendvai, N.; Landgren, O.; Giralt, S. A.; more...
Blood (2015)

Fulltext@MSK | Save

The long PD-1 receptor binding kinetics of nivolumab may increase efficacy of subsequent therapy in relapsed and refractory multiple myeloma patients

Meeting Abstract

Funt, S. A.; Page, D. B.; Cattry, D.; Lendvai, N.; Hassoun, H.; Landgren, O.; Borrello, I. M.; Lesokhin, A. M.
Blood (2015)

Fulltext@MSK | Save

Alliance A061202. A phase I/II study of pomalidomide, dexamethasone and ixazomib versus pomalidomide and dexamethasone for patients with multiple myeloma refractory to lenalidomide and proteasome inhibitor based therapy: Phase I results

Meeting Abstract

Voorhees, P. M.; Mulkey, F.; Hassoun, H.; Paba-Prada, C. E.; Efebera, Y. A.; Hoke, E.; Aquino, G.; Carlisle, D.; Suman, V.; Richardson, P. G.
Blood (2015)

Fulltext@MSK | Save

The majority of patients with relapsing light chain (AL) amyloidosis are not eligible for enrollment onto clinical trials: Using screen failures to define major unmet medical needs

Meeting Abstract

Landau, H.; Comenzo, R. L.; Balasinorwala, T.; Warner, M.; Landgren, O.; Giralt, S. A.; Hassoun, H.
Blood (2015)

Fulltext@MSK | Save

Presence of PD-1 expressing T cells predicts for inferior overall survival in newly diagnosed multiple myeloma

Meeting Abstract

Gasmi, B.; Smith, E. L.; Dogan, A.; Hsu, M.; Devlin, S.; Pichardo, J. D.; Chung, D. J.; Koehne, G.; Korde, N. S.; Landau, H. J.; more...
Blood (2015)

Fulltext@MSK | Save

Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM)

Meeting Abstract

Holstein, S. A.; Owzar, K.; Richardson, P. G.; Jiang, C.; Hofmeister, C. C.; Hassoun, H.; Hurd, D. D.; Stadtmauer, E. A.; Giralt, S.; Devine, S. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Minimal residual disease in multiple myeloma: Bringing the bench to the bedside

Journal Article

Mailankody, S.; Korde, N.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Stetler-Stevenson, M.; Landgren, O.
Nature Reviews Clinical Oncology (2015)

Fulltext@MSK | Save

T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease

Meeting Abstract

Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Giralt, S.
Bone Marrow Transplantation (2015)

Fulltext@MSK | Save

Gain of chromosome 1q portends worse prognosis in multiple myeloma patients treated with novel agent based induction regimens even after autologous transplantation

Meeting Abstract

Shah, G. L.; Landry, C.; Londono, D.; Devlin, S.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
Biology of Blood and Marrow Transplantation (2015)

Fulltext@MSK | Save

Interim analysis of a randomized phase II trial comparing continuous lenalidomide and dexamethasone to autologous stem cell transplantation in multiple myeloma patients responsive to lenalidomide and dexamethasone induction

Meeting Abstract

Weltz, J. I.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; Devlin, S. M.; Riedel, E.; Woo, K. M.; Stellman, A.; Chimento, D.; more...
Blood (2014)

Fulltext@MSK | Save